Research on faulty genetic material by University of Iowa (UI) Carver College of Medicine professor Christopher Ahern recently was licensed by Tevard Biosciences, a company that is seeking to treat certain forms of epilepsy. However, the innovative UI treatment approach being developed by Tevard holds the promise of becoming a platform with medical applications far beyond those for epilepsy. The...